No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Asset Management
Linc AB operates as a private equity and venture capital firm, dedicating its investments to the pharmaceutical, life sciences, and med-tech sectors across early, mid, and late venture stages. The firm prioritizes investment opportunities within Nordic companies. Its typical investment amounts range from SEK 25 million to SEK 250 million, frequently beginning with a relatively smaller initial capital injection, with subsequent follow-up investments constituting the majority of its financial commitment. Linc AB's headquarters are located in Stockholm, Sweden.
linc.seNo one on the platform currently holds LINC.ST.
No tracked institution reports a position in LINC.ST as of their last filing.
No one on the platform has traded LINC.ST yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| LINC.STLinc AB | $71.10 | -0.28% | $4.1B | — |
| CAT-B.STCatella AB (publ) | $18.16 | +0.44% | $1.6B | — |
| ENITY.STEnity Holding AB | $76.30 | -0.39% | $3.8B | — |
| IDUN-B.STIdun Industrier AB (publ) | $311.00 | -0.64% | $3.6B | — |
| KARNEL-B.STKarnell Group AB ser. B | $94.90 | -2.77% | $5.1B | — |
| ORES.STInvestment AB Öresund (publ) | $144.40 | -0.41% | $6.4B | — |
| SVOL-B.STSvolder AB (publ) | $57.55 | +0.44% | $5.6B | — |
Source: Financial Modeling Prep · peers by sector/industry